COVALENT-112: 52-Week Icovamenib Data in Type 1 Diabetes Conference Call Apr 28, 2026 at 8:30 AM EDT Click here for webcast Supporting Materials Icovamenib in Type 1 Diabetes COVALENT-112 Topline Results 1.4 MB
